Pharmalot… Pharmalittle… We’re Back
Make a commentBy Ed Silverman // October 2nd, 2008 // 7:10 am
Hello, everyone. Nice to see you again. Our two-day respite was both sobering and refreshing, and we appreciate the nice wishes many of you sent. Now, though, the usual routine beckons. Please note last night we posted an item about the ImClone drama (scroll down for that one). As always, there is much to do. So grab your cup of stimulation and let’s get started on a brand new day…
Roche Says Genentech Offer Is On Track (The Wall Street Journal)
Feds May Withdraw Ranbaxy Motion (Bloomberg News)
Sanofi Bid For Zentiva Gets Bank Backing (PharmaTimes)
Docs Oppose EU Pharmaceuticals Plan (DutchNews.com)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Genentech, Ranbaxy Laboratories, Roche, Sanofi Aventis, Zentiva